This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $300 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

December 4 - 8, 2022
Marriott Marquis San Diego,
Live In-Person Event: December 4 - 8, 2022


The latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!


Book by midnight Friday October 21, 2022 to save up to $300 on your pass!

Celebrating 33 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices

Brand New Session Themes for 2022:

  • How to Develop an Antibody-based Drug from Discovery to IND?
  • Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
  • Antibody Engineering, Libraries and Selection
  • Novel Targets for Antibody Therapeutics
  • Engineering the Fc Region to Improve Therapeutic Effects
  • Functional Screening Integrated Into Initial Antibody Discovery
  • Miniprotein Engineering
  • Strategies to Engineer Cell-based Immunotherapies

Brand New Session Themes for 2022:

  • Advances with Antibody-based Cellular Engagers
  • Remodeling the Tumor Microenvironment for Cancer Therapy
  • Novel Bispecifics, Multi-specifics and Therapeutic Combinations
  • Advancing Antibody Therapeutics in Immuno-oncology
  • Targeted Conjugates - Antibodies and Novel Platforms
  • Antibodies in Infectious Diseases
  • Progress and Challenges of Computational Approaches for Antibody Discovery and Engineering

3 Unmissable Add-On Options

Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference. 

Options include:

  • Pre-Conference Half-Day Workshop A (PM): How to Develop an Antibody-based Drug from Discovery to IND?
  • Pre-Conference Half-Day Workshop B (PM): Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
  • Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering

Michael Kierny, PhD

Scientist I


With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Blake Shuka | (+1) 212-600-3451

About the Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field. 

We are:

  • Creating opportunities for education and networking;
  • Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
  • Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
  • Engaging government and international agencies on matters concerning the antibody community;

 Please join us!

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19

Informa AllSecure

Vaishali Kapoor


Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.